| Product Code: ETC7919558 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of pregabalin to Latvia in 2024 saw a significant increase in concentration, with top exporting countries being Ukraine, India, Denmark, Metropolitan France, and Germany. The Herfindahl-Hirschman Index (HHI) indicated very high concentration levels, reflecting a competitive market landscape. Despite a negative compound annual growth rate (CAGR) from 2020 to 2024, there was a notable growth rate of 9.23% from 2023 to 2024, suggesting a positive uptick in demand for pregabalin in Latvia. This data highlights the evolving dynamics of the pharmaceutical market in the country.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Pregabalin Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Pregabalin Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Pregabalin Market - Industry Life Cycle |
3.4 Latvia Pregabalin Market - Porter's Five Forces |
3.5 Latvia Pregabalin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Latvia Pregabalin Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Latvia Pregabalin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia Pregabalin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in Latvia |
4.2.2 Growing awareness about the benefits of pregabalin in managing neuropathic pain |
4.2.3 Rise in healthcare expenditure and focus on improving access to pain management therapies |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for prescribing pregabalin |
4.3.2 Competition from alternative pain management therapies |
4.3.3 Limited reimbursement policies for pregabalin in Latvia |
5 Latvia Pregabalin Market Trends |
6 Latvia Pregabalin Market, By Types |
6.1 Latvia Pregabalin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Latvia Pregabalin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Latvia Pregabalin Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.1.4 Latvia Pregabalin Market Revenues & Volume, By Neuropathic Pain, 2021- 2031F |
6.1.5 Latvia Pregabalin Market Revenues & Volume, By Anxiety Disorder, 2021- 2031F |
6.1.6 Latvia Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Latvia Pregabalin Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Latvia Pregabalin Market Revenues & Volume, By Fibromyalgia Agents, 2021- 2031F |
6.2.3 Latvia Pregabalin Market Revenues & Volume, By Anticonvulsants, 2021- 2031F |
6.2.4 Latvia Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Latvia Pregabalin Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Latvia Pregabalin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Latvia Pregabalin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 Latvia Pregabalin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.5 Latvia Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Pregabalin Market Import-Export Trade Statistics |
7.1 Latvia Pregabalin Market Export to Major Countries |
7.2 Latvia Pregabalin Market Imports from Major Countries |
8 Latvia Pregabalin Market Key Performance Indicators |
8.1 Average prescription rate of pregabalin by healthcare providers |
8.2 Patient adherence rate to pregabalin treatment regimens |
8.3 Number of clinical trials or studies supporting the efficacy of pregabalin in Latvia |
9 Latvia Pregabalin Market - Opportunity Assessment |
9.1 Latvia Pregabalin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Latvia Pregabalin Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Latvia Pregabalin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia Pregabalin Market - Competitive Landscape |
10.1 Latvia Pregabalin Market Revenue Share, By Companies, 2024 |
10.2 Latvia Pregabalin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here